Roche Finance Ltd - Significant Ownership

Signature - Title
/s/ Carole Nuechterlein - Carole Nuechterlein, Authorized Signatory
Location
Basel Switzerland, Switzerland
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Roche Finance Ltd.

Significant Ownership of Roche Finance Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TRDA Entrada Therapeutics, Inc. Common Stock, $0.0001 par value per share 6.9% $21M 2.57M Roche Finance Ltd Dec 31, 2024

Schedules 13D/G Reported by Roche Finance Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.